PARP expression occurred in 54% of processed tumor samples and high PARP expression associated with shorter overall survival (36 vs. 43 months, p = 0.04, HR 0.71) but the BRCA status was not examined here neither [17]. The gene discussed is PARP1; the disease is neoplasm.